Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Colonic Neoplasms × nilotinib × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neurofibromatoses 1 Neurofibroma, Plexiform 1 Neurofibroma 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Colonic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 3 Fluorouracil 3 Oxaliplatin 2 Leucovorin 2 Cholecalciferol 2 Cetuximab 2 sodium thiosulfate 1 nilotinib 1 gallium 68 PSMA-11 1 epigallocatechin gallate 1 delta-8-tetrahydrocannabinol 1 clevudine 1 X-Rays 1 Vaccines 1 Tea 1 Specimen Handling 1 Reverse Transcriptase Polymerase Chain Reaction 1 Radiotherapy 1 Platinum 1 Pentoxifylline 1 Panitumumab 1 Microscopy, Electron 1 Metastasectomy 1 Irinotecan 1 Hyperthermic Intraperitoneal Chemotherapy 1 Folfox protocol 1 Fluorodeoxyglucose F18 1 FAPI-46 1 Epidermal Growth Factor 1 Enzyme-Linked Immunosorbent Assay 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02774512 2017-10-06

ZAK-0

Institut Bergonié

Phase EARLY_PHASE1 Withdrawn

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡